Despite minor effects in primary tumor growth upon LOX inhibition or PD-1 blockade treatment alone, their combination increases effector CD8 T cell accumulation in tumors and significantly delays tumor progression in a pancreatic cancer model. This evidence concerns the gene LOX and neoplasm.